P. Schöffski

Predictive impact of DNA repair functionality on clinical outcome of advanced sarcoma patients treated with trabectedin: a retrospective multicentric study.

J. Blay, F. Grosso, A. Cesne, 2011, European journal of cancer.

Final results from the large sunitinib global expanded-access trial in metastatic renal cell carcinoma

C. Porta, M. Gore, L. Crinò, 2015, British Journal of Cancer.

CLINICAL Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up † the ESMO Guidelines Committee and EURACAN*

E. Álava, A. Cesne, H. Joensuu, 2020 .

Growth modulation index as metric of clinical benefit assessment among advanced soft tissue sarcoma patients receiving trabectedin as a salvage therapy.

I Judson, J Verweij, J. Blay, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical implications of mutational analysis in gastrointestinal stromal tumours

M. Debiec‐Rychter, P. Schöffski, A. Hoeben, 2008, British Journal of Cancer.

Anti-tumor activity of the MDM2-TP53 inhibitor BI-907828 in dedifferentiated liposarcoma patient-derived xenograft models harboring MDM2 amplification

R. Sciot, M. Debiec‐Rychter, P. Schöffski, 2019, Clinical and Translational Oncology.

Paclitaxel and carboplatin vs gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: a randomised prospective phase II trial

P. Schőffski, G. Folprecht, S. Al-Batran, 2008, British Journal of Cancer.

Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

S. Sleijfer, E. Álava, E. Wardelmann, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

PALETTE: A randomized, double-blind, phase III trial of pazopanib versus placebo in patients (pts) with soft-tissue sarcoma (STS) whose disease has progressed during or following prior chemotherapy-An EORTC STBSG Global Network Study (EORTC 62072).

J. Blay, A. Cesne, A. D. Dei Tos, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single-nucleotide polymorphisms associated with outcome in metastatic renal cell carcinoma treated with sunitinib

J. Patard, D. Lambrechts, J. Zucman‐Rossi, 2013, British Journal of Cancer.

Activity and safety of crizotinib in patients with alveolar soft part sarcoma with rearrangement of TFE3: European Organization for Research and Treatment of Cancer (EORTC) phase II trial 90101 ‘CREATE’

J. Blay, S. Aamdal, R. Sciot, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.